Biomerieux SA
SWB:EYWN

Watchlist Manager
Biomerieux SA Logo
Biomerieux SA
SWB:EYWN
Watchlist
Price: 71.55 EUR -22.48% Market Closed
Market Cap: €8.5B

Wall St Price Targets

EYWN Price Targets Summary
Biomerieux SA

Wall Street analysts forecast EYWN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EYWN is 98.46 EUR with a low forecast of 72.36 EUR and a high forecast of 145 EUR.

Lowest Forecast
Price Target
72.36 EUR
1% Upside
Average Forecast
Price Target
98.46 EUR
38% Upside
Highest Forecast
Price Target
145 EUR
103% Upside
Biomerieux SA Competitors:
Price Targets
NKTX
Nkarta Inc
277% Upside
XNCR
Xencor Inc
156% Upside

Revenue
Forecast

8% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
8% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 5%.

Operating Income
Forecast

7% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
7% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 5 years is 8%.

Net Income
Forecast

7% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
7% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 5 years is 14%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is EYWN's stock price target?
Price Target
98.46 EUR

According to Wall Street analysts, the average 1-year price target for EYWN is 98.46 EUR with a low forecast of 72.36 EUR and a high forecast of 145 EUR.

What is the Revenue forecast for Biomerieux SA?
Projected CAGR
5%

Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 5%.

What is the Operating Income forecast for Biomerieux SA?
Projected CAGR
8%

Over the last 14 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 5 years is 8%.

What is the Net Income forecast for Biomerieux SA?
Projected CAGR
14%

Over the last 14 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 5 years is 14%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett